Skip to ContentSkip to Navigation
Research Pediatrics
University Medical Center Groningen

New Key Publication: Endogenous glucose production in patients with glycogen storage disease type Ia estimated by oral d-[6,6-2H2]-glucose

10 September 2023

Abstract

Context: Glycogen storage disease type Ia (GSDIa) is an inborn metabolic disorder characterized by impaired endogenous glucose production (EGP). Monitoring of GSDIa patients is prioritized, because of ongoing treatment developments. Stable isotope tracers may enable reliable EGP monitoring.

Objective: The aim of this study was to prospectively assessthe rate of appearance of endogenous glucose into the bloodstream (Ra) in GSDIa patients after a single oral d-[6,6-2H2]-glucose dose.

Design: Ten adult GSDIa patients and ten age-, sex-, BMI-matched healthy volunteers (HV) were enrolled. For each participant, three oral glucose tracer tests were performed: 1) preprandial/fasted, 2) postprandial, and 3) randomly fed states. Dried blood spots were collected before d-[6,6-2H2]-glucose administration and 10, 20, 30, 40, 50, 60, 75, 90, 120 minutes thereafter.

Results: Glucose Ra in fasted HV was consistent with previously reported data. The time-averaged glucose Ra was significantly higher in i) preprandial/fasted GSDIa patients than HV and ii) postprandial HV compared to fasted HV(p<0.05). A progressive decrease in glucose Ra was observed in preprandial/fasted GSDIa patients; the change in glucose Ra time-course was directly correlated with the change in capillary glucose (p<0.05).

Conclusions: This is the first study to quantify glucose Ra in GSDIa patients using oral d-[6,6-2H2] glucose. The test can reliably estimate EGP under conditions in which fasting tolerance is unaffected but does not discriminate between relative contributions of EGP (e.g., liver, kidney) and exogenous sources (e.g., dietary cornstarch). Future application is warranted for longitudinal monitoring after novel genome-based treatments in GSDIa patients in whom nocturnal dietary management can be discontinued.

Authors:

  • Alessandro Rossi
  • Maaike H Oosterveer
  • Theo H van Dijk
  • Aycha Bleeker
  • Martijn Koehorst
  • David A Weinstein
  • Barbara M Bakker
  • Terry G J Derks

Read More: The Journal of Clinical Endocrinology & Metabolism: https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgad537/7266790?login=true

Last modified:11 September 2023 09.49 a.m.

More news

  • 12 September 2023

    Art in times of AI

    Leonardo Arriagada Beltran conducted his PhD research on the interface of computer-generated art and the constantly evolving field of Artificial Intelligence (AI). He will defend his Phd thesis on 21 September. His research offers valuable insights...

  • 28 August 2023

    Harish Vedantham and Casper van der Kooi nominated for 'Wetenschapstalent 2023'

    Harish Vedantham and Casper van der Kooi have been nominated by New Scientist for Wetenschapstalent 2023 (Science Talent 2023). This election is meant to give young scientists and their research a stage.

  • 26 July 2023

    Five promising UG researchers to top institutes abroad on Rubicon grants

    No less than five promising PhD graduates from the University of Groningen will be able to conduct research at top institutes abroad for two years thanks to the Rubicon programme organized by the Netherlands Organisation for Scientific Research...